The Manufacturers Life Insurance Company reduces its investment in Nuvation Bio by 62.5%, indicating a shift in investment strategy. Discover the implications now.

Tonix Pharmaceuticals expands Medicare coverage for TONMYA®, improving access for 9M beneficiaries. Discover innovations in fibromyalgia treatments.

Pennsylvania Senate Bill 1211 ensures health insurance covers biomarker tests for cancer and ALS, improving access to personalized treatments for patients statewide.

Explore recent healthcare financial results, including Centene's share drop and Medicare premium hikes affecting seniors. Understand the regulatory implications.

Discover how Insilico Medicine's IPO on the Hong Kong Exchange is revolutionizing drug discovery with AI, drawing significant investor interest and market confidence.

Personalis updates valuation with a raised fair value to $11 per share driven by Medicare reimbursement for its NeXT Personal test and strong Q3 revenue performance. Analysts see durable revenue growth and clinical validation as key drivers.

Explore how the aging U.S. population is fueling AI healthcare innovation, annuity growth, and healthspan technologies, creating new investment opportunities in longevity markets.

Analysis of the ACA's unfunded mandates on insurance markets highlights premium impacts and market consolidation. Also, U.S. biotechnology patent leadership narrows amid rising Chinese innovation.